MedTrace Logo

the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD

NCT03681704 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2022-05-11

No results posted yet for this study

Summary

Efficacy and Safety of treatment with Traditional Chinese Medicine HuangQi Decoctions in Patients with early stage of Diabetic Kidney Disease.

Conditions

  • Diabetic Nephropathy Type 2

Interventions

DRUG

HuangQi Decoction

HuangQi Decoction 150ml twice a day for 24 weeks

DRUG

HuangQi Decoction placebo

traditional Chinese medicine placebo mimic HuangQi Decoction 150ml twice a day for 24 weeks

Sponsors & Collaborators

  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital

    collaborator OTHER

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Yueyi Deng, PhD · Shanghai University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-08
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681704 on ClinicalTrials.gov